Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB-WT) Free Cash Flow (2023 - 2025)

Nuvation Bio (NUVB-WT) has disclosed Free Cash Flow for 3 consecutive years, with -$29.7 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 36.08% to -$29.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$181.4 million through Dec 2025, down 38.92% year-over-year, with the annual reading at -$181.4 million for FY2025, 38.92% down from the prior year.
  • Free Cash Flow for Q4 2025 was -$29.7 million at Nuvation Bio, up from -$60.6 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$15.0 million in Q4 2023, with the low at -$60.6 million in Q3 2025.
  • Average Free Cash Flow over 3 years is -$31.7 million, with a median of -$30.4 million recorded in 2024.
  • The sharpest move saw Free Cash Flow crashed 208.9% in 2024, then skyrocketed 36.08% in 2025.
  • Over 3 years, Free Cash Flow stood at -$15.0 million in 2023, then plummeted by 208.9% to -$46.5 million in 2024, then surged by 36.08% to -$29.7 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$29.7 million, -$60.6 million, and -$48.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.